Skip to main content
Premium Trial:

Request an Annual Quote

GigaScience Selects Aspera's Software to Move Research Data


Aspera said this week that GigaScience — an online open-access, open-data life sciences journal, co-published by BGI and BioMed Central — has licensed its software products to provide authors, reviewers, and other users with tools to upload and download large datasets that accompany submitted manuscripts.

Aspera said that GigaScience selected its Aspera Connect Server and Aspera Console to enable the transfer of the datasets and to manage and monitor the transfer process.

GigaScience publishes articles that span the full spectrum of biological and biomedical sciences and focus on the use, analysis, or tool development for large-scale data sets. It also hosts the complete datasets associated with each published article in a comprehensive public database, GigaDB.

Manuscript authors will now be able to use Aspera's free Connect Web Browser plug-in to submit manuscript-associated datasets to a private data storage site at GigaScience that staff reviewers will be able access and download data from. If a paper is accepted for publishing, the data will then be transferred to GigaDB where it will be readily available for readers to download.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.